Enrica Calura

Dr. Enrica Calura


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2012 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
GSGabriele Sales
Gabriele Sales
ECEnrica Calura
Enrica Calura
DCDuccio Cavalieri
Duccio Cavalieri
CRChiara Romualdi
Chiara Romualdi
Background: Gene set analysis is moving towards considering pathway topology as a crucial feature. Pathway elements are complex entities such as protein complexes, gene family members and chemical compounds. The conversion of pathway topology to a gene/protein networks (where nodes are a simple element like a gene/protein) is a critical and challenging task that enables topology-based gene set analyses. Unfortunately, currently available R/Bioconductor packages provide pathway networks only from single databases. They do not propagate signals through chemical compounds and do not differentiate between complexes and gene families. Results: Here we present , a Bioconductor package addressing these issues. Pathway information from four different databases is interpreted following specific biologically-driven rules that allow the reconstruction of gene-gene networks taking into account protein complexes, gene families and sensibly removing chemical compounds from the final graphs. The resulting networks represent a uniform resource for pathway analyses. Indeed, graphite provides easy access to three recently proposed topological methods. The package is available as part of the Bioconductor software suite. Conclusions: is an innovative package able to gather and make easily available the contents of the four major pathway databases. In the field of topological analysis acts as a provider of biological information by reducing the pathway complexity considering the biological meaning of the pathway elements.

1 March 2011 in The Lancet Oncology
Verified
Journal Article
Closed access
SMSergio Marchini
Sergio Marchini
DCDuccio Cavalieri
Duccio Cavalieri
RFRobert Fruscio
Robert Fruscio
ECEnrica Calura
Enrica Calura
DGDaniela Garavaglia
Daniela Garavaglia
Maurizio D'IncalciMaurizio D'Incalci
Maurizio D'Incalci

1 March 2017 in Cancer Letters
Verified
Journal Article
Closed access
PTPaola Todeschini
Paola Todeschini
ESElisa Salviato
Elisa Salviato
LPLara Paracchini
Lara Paracchini
MFManuela Ferracin
Manuela Ferracin
MPMarco Petrillo
Marco Petrillo
CRChiara Romualdi
Chiara Romualdi

30 April 2017 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
Paolo MartiniPaolo Martini
Paolo Martini
LPLara Paracchini
Lara Paracchini
GCGiulia Caratti
Giulia Caratti
MMMaurizia Mello-Grand
Maurizia Mello-Grand
RFRobert Fruscio
Robert Fruscio
CRChiara Romualdi
Chiara Romualdi
Purpose: Stage I epithelial ovarian cancer (EOC) represents about 10% of all EOCs and is characterized by good prognosis with fewer than 20% of patients relapsing. As it occurs less frequently than advanced-stage EOC, its molecular features have not been thoroughly investigated. We have demonstrated that in stage I EOC miR-200c-3p can predict patients' outcome. In the present study, we analyzed the expression of long non-coding RNAs (lncRNA) to enable potential definition of a non-coding transcriptional signature with prognostic relevance for stage I EOC. Experimental Design: 202 snap-frozen stage I EOC tumor biopsies, 47 of which relapsed, were gathered together from three independent tumor tissue collections and subdivided into a training set (n = 73) and a validation set (n = 129). Median follow up was 9 years. LncRNAs' expression profiles were correlated in univariate and multivariate analysis with overall survival (OS) and progression-free survival (PFS). Results: The expression of lnc-SERTAD2-3, lnc-SOX4-1, lnc-HRCT1-1, and PVT1 was associated in univariate and multivariate analyses with relapse and poor outcome in both training and validation sets (P < 0.001). Using the expression profiles of PVT1, lnc-SERTAD2-3, and miR-200c-3p simultaneously, it was possible to stratify patients into high and low risk. The OS for high- and low-risk individuals are 36 and 123 months, respectively (OR, 15.55; 95% confidence interval, 3.81–63.36). Conclusions: We have identified a non-coding transcriptional signature predictor of survival and biomarker of relapse for stage I EOC. Clin Cancer Res; 23(9); 2356–66. ©2016 AACR.

10 July 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
GSGiuseppina Della Vittoria Scarpati
Giuseppina Della Vittoria Scarpati
ECEnrica Calura
Enrica Calura
MMMariacristina Di Marino
Mariacristina Di Marino
CRChiara Romualdi
Chiara Romualdi
LBLuca Beltrame
Luca Beltrame
CCChiara Carlomagno
Chiara Carlomagno
Microarray technology was used to profile miRNA expression in primary tumor and stromal tissue from paraffin embedded material of 51 patients with colorectal cancer. 26 miRNAs resulted differentially expressed with at least 2-fold change in tumor tissue with respect to stroma (16 more expressed in the tumor and 10 more expressed in the stroma). 10/26 were confirmed as differentially expressed at qRTPCR: miR-200c-3p, miR-141-3p, miR-200b-3p, miR-200a-3p, miR-1246, miR-92a-3p, miR-194-5p, miR-192-5p, miR-3651-5p, and miR-574-3p. No significant association was found between miRNA expressions and stage at diagnosis, site of primary tumor, first site of metastasis, progression-free, or overall survival.

10 May 2013 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
GSGabriele Sales
Gabriele Sales
ECEnrica Calura
Enrica Calura
Paolo MartiniPaolo Martini
Paolo Martini
CRChiara Romualdi
Chiara Romualdi
Graphite web is a novel web tool for pathway analyses and network visualization for gene expression data of both microarray and RNA-seq experiments. Several pathway analyses have been proposed either in the univariate or in the global and multivariate context to tackle the complexity and the interpretation of expression results. These methods can be further divided into ‘topological’ and ‘non-topological’ methods according to their ability to gain power from pathway topology. Biological pathways are, in fact, not only gene lists but can be represented through a network where genes and connections are, respectively, nodes and edges. To this day, the most used approaches are non-topological and univariate although they miss the relationship among genes. On the contrary, topological and multivariate approaches are more powerful, but difficult to be used by researchers without bioinformatic skills. Here we present Graphite web, the first public web server for pathway analysis on gene expression data that combines topological and multivariate pathway analyses with an efficient system of interactive network visualizations for easy results interpretation. Specifically, Graphite web implements five different gene set analyses on three model organisms and two pathway databases. Graphite Web is freely available at http://graphiteweb.bio.unipd.it/.